Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

A portable device for nucleic acid quantification powered by sunlight, a flame or electricity.

Snodgrass R, Gardner A, Semeere A, Kopparthy VL, Duru J, Maurer T, Martin J, Cesarman E, Erickson D.

Nat Biomed Eng. 2018 Sep;2(9):657-665. doi: 10.1038/s41551-018-0286-y. Epub 2018 Sep 11.

2.

Kaposi sarcoma.

Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D.

Nat Rev Dis Primers. 2019 Jan 31;5(1):9. doi: 10.1038/s41572-019-0060-9. Review.

3.

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.

Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W; AIDS Malignancy Consortium.

Blood Adv. 2018 Dec 26;2(24):3618-3626. doi: 10.1182/bloodadvances.2018022095.

4.

Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells.

Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, Mahapatro M, Greten FR, Hu Y, Neurath MF, Cesarman E, Ballon G, Günther C, Becker C.

Mucosal Immunol. 2018 Nov;11(6):1621-1629. doi: 10.1038/s41385-018-0068-6. Epub 2018 Aug 13.

PMID:
30104627
5.

Mast Cell Activation and KSHV Infection in Kaposi Sarcoma.

Ayers LW, Barbachano-Guerrero A, McAllister SC, Ritchie JA, Asiago-Reddy E, Bartlett LC, Cesarman E, Wang D, Rochford R, Martin JN, King CA.

Clin Cancer Res. 2018 Oct 15;24(20):5085-5097. doi: 10.1158/1078-0432.CCR-18-0873. Epub 2018 Jul 3.

6.

KSHV induces immunoglobulin rearrangements in mature B lymphocytes.

Totonchy J, Osborn JM, Chadburn A, Nabiee R, Argueta L, Mikita G, Cesarman E.

PLoS Pathog. 2018 Apr 16;14(4):e1006967. doi: 10.1371/journal.ppat.1006967. eCollection 2018 Apr.

7.

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075).

Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A.

Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):180-190.e2. doi: 10.1016/j.clml.2018.01.004. Epub 2018 Feb 2.

8.

Editorial overview: Viruses and cancer: How tumor viruses affect the cellular genome.

Schulz TF, Cesarman E.

Curr Opin Virol. 2017 Oct;26:vi-vii. doi: 10.1016/j.coviro.2017.10.005. No abstract available.

PMID:
29107266
9.

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

McHugh D, Caduff N, Barros MHM, Rämer PC, Raykova A, Murer A, Landtwing V, Quast I, Styles CT, Spohn M, Fowotade A, Delecluse HJ, Papoudou-Bai A, Lee YM, Kim JM, Middeldorp J, Schulz TF, Cesarman E, Zbinden A, Capaul R, White RE, Allday MJ, Niedobitek G, Blackbourn DJ, Grundhoff A, Münz C.

Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7. doi: 10.1016/j.chom.2017.06.009.

10.

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma.

Reichel JB, McCormick J, Fromm JR, Elemento O, Cesarman E, Roshal M.

J Vis Exp. 2017 Jun 10;(124). doi: 10.3791/54399.

11.

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, Bolaender A, Erdjument-Bromage H, Sadek J, Chadburn A, Barth MJ, Dela Cruz FS, Rainey A, Kung AL, Chiosis G, Cesarman E.

Mol Cancer Ther. 2017 Sep;16(9):1779-1790. doi: 10.1158/1535-7163.MCT-16-0848. Epub 2017 Jun 15.

12.

Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.

Nayar U, Sadek J, Reichel J, Hernandez-Hopkins D, Akar G, Barelli PJ, Sahai MA, Zhou H, Totonchy J, Jayabalan D, Niesvizky R, Guasparri I, Hassane D, Liu Y, Sei S, Shoemaker RH, Warren JD, Elemento O, Kaye KM, Cesarman E.

J Clin Invest. 2017 Jun 1;127(6):2066-2080. doi: 10.1172/JCI83936. Epub 2017 May 15.

13.

The epichaperome is an integrated chaperome network that facilitates tumour survival.

Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, Pressl C, Peter RI, Xu C, Trondl R, Patel HJ, Shimizu F, Bolaender A, Yang C, Panchal P, Farooq MF, Kishinevsky S, Modi S, Lin O, Chu F, Patil S, Erdjument-Bromage H, Zanzonico P, Hudis C, Studer L, Roboz GJ, Cesarman E, Cerchietti L, Levine R, Melnick A, Larson SM, Lewis JS, Guzman ML, Chiosis G.

Nature. 2016 Oct 20;538(7625):397-401. doi: 10.1038/nature19807. Epub 2016 Oct 5.

14.

Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Totonchy J, Cesarman E.

Curr Opin Virol. 2016 Oct;20:71-77. doi: 10.1016/j.coviro.2016.09.001. Epub 2016 Sep 23. Review.

15.

KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples.

Snodgrass R, Gardner A, Jiang L, Fu C, Cesarman E, Erickson D.

PLoS One. 2016 Jan 22;11(1):e0147636. doi: 10.1371/journal.pone.0147636. eCollection 2016.

16.

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

Schulz TF, Cesarman E.

Curr Opin Virol. 2015 Oct;14:116-28. doi: 10.1016/j.coviro.2015.08.016. Epub 2015 Sep 29. Review.

PMID:
26431609
17.

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.

Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L; AIDS Malignancy Consortium.

Blood. 2015 Jul 9;126(2):160-6. doi: 10.1182/blood-2015-01-623900. Epub 2015 May 8.

18.

The tumor virus landscape of AIDS-related lymphomas.

Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E.

Blood. 2015 May 14;125(20):e14-22. doi: 10.1182/blood-2014-11-599951. Epub 2015 Mar 31.

19.

Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo.

Ballon G, Akar G, Cesarman E.

PLoS Pathog. 2015 Jan 21;11(1):e1004581. doi: 10.1371/journal.ppat.1004581. eCollection 2015 Jan.

20.

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M.

Blood. 2015 Feb 12;125(7):1061-72. doi: 10.1182/blood-2014-11-610436. Epub 2014 Dec 8.

PMID:
25488972
21.

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC.

J Clin Invest. 2015 Jan;125(1):304-15. doi: 10.1172/JCI76357. Epub 2014 Dec 8.

22.

KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo.

Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, Evan GI, Cesarman E, Verschuren EW, Ojala PM.

Cell Cycle. 2014;13(23):3670-84. doi: 10.4161/15384101.2014.964118.

23.

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.

Vogel MJ, Xie L, Guan H, Tooze RM, Maier T, Kostezka U, Maier HJ, Holzmann K, Chan FC, Steidl C, Reichel JB, Weitzer CD, Gehringer F, Kick AB, Cesarman E, Roshal M, Gascoyne RD, Möller P, Wirth T, Ushmorov A.

Blood. 2014 Nov 13;124(20):3118-29. doi: 10.1182/blood-2014-07-590570. Epub 2014 Sep 17.

PMID:
25232062
24.

Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessory.

Mancuso M, Cesarman E, Erickson D.

Lab Chip. 2014 Oct 7;14(19):3809-16. doi: 10.1039/c4lc00517a.

25.

How do viruses trick B cells into becoming lymphomas?

Cesarman E.

Curr Opin Hematol. 2014 Jul;21(4):358-68. doi: 10.1097/MOH.0000000000000060. Review.

26.

Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics.

Jiang L, Mancuso M, Lu Z, Akar G, Cesarman E, Erickson D.

Sci Rep. 2014 Feb 20;4:4137. doi: 10.1038/srep04137.

27.

Gammaherpesviruses and lymphoproliferative disorders.

Cesarman E.

Annu Rev Pathol. 2014;9:349-72. doi: 10.1146/annurev-pathol-012513-104656. Epub 2013 Oct 9. Review.

PMID:
24111911
28.

The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1.

Wong LY, Brulois K, Toth Z, Inn KS, Lee SH, O'Brien K, Lee H, Gao SJ, Cesarman E, Ensser A, Jung JU.

J Virol. 2013 Nov;87(22):12069-79. doi: 10.1128/JVI.01900-13. Epub 2013 Aug 28.

29.

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.

Nayar U, Lu P, Goldstein RL, Vider J, Ballon G, Rodina A, Taldone T, Erdjument-Bromage H, Chomet M, Blasberg R, Melnick A, Cerchietti L, Chiosis G, Wang YL, Cesarman E.

Blood. 2013 Oct 17;122(16):2837-47. doi: 10.1182/blood-2013-01-479972. Epub 2013 Aug 13.

30.

Pathology of lymphoma in HIV.

Cesarman E.

Curr Opin Oncol. 2013 Sep;25(5):487-94. doi: 10.1097/01.cco.0000432525.70099.a4. Review.

31.

Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.

Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, Canpolat N, Aydogan G, Fleckenstein B, Bustamante J, Picard C, Gessain A, Jouanguy E, Cesarman E, Olivier M, Gros P, Abel L, Croft M, Tangye SG, Casanova JL.

J Exp Med. 2013 Aug 26;210(9):1743-59. doi: 10.1084/jem.20130592. Epub 2013 Jul 29.

32.

Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles.

Mancuso M, Jiang L, Cesarman E, Erickson D.

Nanoscale. 2013 Feb 21;5(4):1678-86. doi: 10.1039/c3nr33492a.

33.

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.

Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A.

J Clin Oncol. 2013 Jan 1;31(1):58-64. doi: 10.1200/JCO.2012.42.4648. Epub 2012 Nov 19.

34.

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

Giulino-Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, Rogena E, Pinkney KA, Rubin MA, Ribeiro RC, Yelensky R, Tam W, Stephens PJ, Cesarman E.

Blood. 2012 Dec 20;120(26):5181-4. doi: 10.1182/blood-2012-06-437624. Epub 2012 Oct 22.

35.

Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.

Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB.

Br J Haematol. 2012 Aug;158(4):539-47. doi: 10.1111/j.1365-2141.2012.09184.x. Epub 2012 Jul 6.

PMID:
22775462
36.

Viral lymphomas: can antivirals be used to treat cancer?

Cesarman E.

Hematology. 2012 Apr;17 Suppl 1:S83-6. doi: 10.1179/102453312X13336169155899.

PMID:
22507788
37.

Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D.

Mesri EA, Cesarman E.

Cell Host Microbe. 2011 Dec 15;10(6):529-31. doi: 10.1016/j.chom.2011.11.008.

38.

Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.

Krown SE, Roy D, Lee JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):447-54. doi: 10.1097/QAI.0b013e31823e7884.

39.

Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Cesarman E.

Cancer Lett. 2011 Jun 28;305(2):163-74. doi: 10.1016/j.canlet.2011.03.003. Epub 2011 Apr 13. Review.

40.

Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.

Krown SE, Dittmer DP, Cesarman E.

J Infect Dis. 2011 Apr 15;203(8):1082-6. doi: 10.1093/infdis/jiq177.

41.

A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E.

Blood. 2011 May 5;117(18):4852-4. doi: 10.1182/blood-2010-10-310995. Epub 2011 Mar 15.

42.

Clinical and pathological aspects of EBV and KSHV infection.

Ambinder RF, Cesarman E.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 50.

43.

Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.

Ballon G, Chen K, Perez R, Tam W, Cesarman E.

J Clin Invest. 2011 Mar;121(3):1141-53. doi: 10.1172/JCI44417. Epub 2011 Feb 21.

44.

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM, Lacasce A, Morrison J, Elstrom R, Ely S, Chadburn A, Cesarman E, Coleman M, Leonard JP.

J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.

PMID:
21189393
45.

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.

Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):64-8. doi: 10.1097/QAI.0b013e3181fc0141.

46.

Kaposi's sarcoma and its associated herpesvirus.

Mesri EA, Cesarman E, Boshoff C.

Nat Rev Cancer. 2010 Oct;10(10):707-19. doi: 10.1038/nrc2888. Review.

47.

NF-κB as a target for oncogenic viruses.

Sun SC, Cesarman E.

Curr Top Microbiol Immunol. 2011;349:197-244. doi: 10.1007/82_2010_108. Review.

48.

Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.

Luan SL, Boulanger E, Ye H, Chanudet E, Johnson N, Hamoudi RA, Bacon CM, Liu H, Huang Y, Said J, Chu P, Clemen CS, Cesarman E, Chadburn A, Isaacson PG, Du MQ.

J Pathol. 2010 Oct;222(2):166-79. doi: 10.1002/path.2752.

PMID:
20690162
49.

NF-kappaB signaling modulation by EBV and KSHV.

de Oliveira DE, Ballon G, Cesarman E.

Trends Microbiol. 2010 Jun;18(6):248-57. doi: 10.1016/j.tim.2010.04.001. Epub 2010 May 6. Review.

PMID:
20452220
50.

Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

Carbone A, Cesarman E, Gloghini A, Drexler HG.

AIDS. 2010 Feb 20;24(4):479-90. doi: 10.1097/QAD.0b013e3283365395. Review.

Supplemental Content

Loading ...
Support Center